Compugen Earnings

The next earnings date for Compugen is November 6, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Compugen Earnings

Report Date	Estimated Earnings Per Share
11/06/2025	$-0.07

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Compugen Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
07/31/2025	---	$0	100.00%
05/19/2025	Before Market	---	---
03/04/2025	Before Market	$-0.07	6.67%
11/12/2024	Before Market	$0.01	-85.80%
08/06/2024	Before Market	$-0.02	71.43%
05/20/2024	Before Market	$-0.08	-300.00%
03/05/2024	Before Market	$0.11	-52.17%
11/07/2023	Before Market	$-0.11	-22.22%
08/07/2023	Before Market	$-0.11	8.33%
05/15/2023	Before Market	$-0.11	8.33%
02/27/2023	Before Market	$-0.04	71.43%
11/14/2022	Before Market	$-0.14	-7.69%
08/04/2022	Before Market	$-0.11	8.33%
05/16/2022	Before Market	$-0.11	8.33%
02/24/2022	Before Market	$-0.10	28.57%
11/12/2021	Before Market	$-0.07	41.67%
07/28/2021	Before Market	$-0.11	8.33%
05/13/2021	Before Market	$-0.12	7.69%
02/25/2021	Before Market	$-0.10	0.00%
11/05/2020	Before Market	$-0.09	0.00%
07/30/2020	Before Market	$-0.08	20.00%
05/06/2020	Before Market	$-0.10	0.00%
02/20/2020	Before Market	$-0.10	9.09%
11/11/2019	Before Market	$-0.10	0.00%
08/05/2019	Before Market	$-0.10	28.57%
05/20/2019	Before Market	$-0.14	17.65%
02/26/2019	Before Market	$-0.16	15.79%
11/07/2018	Before Market	$-0.05	66.67%
08/01/2018	Before Market	$-0.19	0.00%
05/09/2018	Before Market	$0.00	101.05%
02/21/2018	Before Market	$-0.18	10.00%
11/07/2017	Before Market	$-0.19	0.00%
08/02/2017	Before Market	$-0.18	0.00%
05/11/2017	Before Market	$-0.17	0.00%
02/15/2017	After Market	$-0.17	0.00%
11/07/2016	Before Market	$-0.15	-15.38%
08/02/2016	Before Market	$-0.13	23.53%
05/10/2016	Before Market	$-0.17	-13.33%
02/09/2016	Before Market	$-0.01	90.91%
11/03/2015	Before Market	$-0.13	13.33%
08/04/2015	Before Market	$-0.14	-16.67%
05/05/2015	Before Market	$-0.12	-20.00%
02/10/2015	Before Market	$-0.03	72.73%
10/29/2014	After Market	$-0.11	0.00%
08/06/2014	---	$-0.05	54.55%
05/19/2014	---	$-0.04	60.00%
02/11/2014	---	$-0.07	41.67%
10/29/2013	---	$-0.12	-20.00%
08/07/2013	---	$-0.08	---
04/25/2013	---	$-0.09	---
02/20/2013	---	$-0.15	---
11/05/2012	---	$-0.10	---
08/07/2012	---	$-0.02	---
05/01/2012	---	$-0.12	---
02/07/2012	---	$-0.13	-30.00%
11/08/2011	---	$-0.10	-11.11%
08/02/2011	---	$-0.06	25.00%
05/11/2011	---	$-0.06	14.29%
02/15/2011	---	$-0.06	---
10/26/2010	---	$-0.05	---
07/27/2010	---	$-0.03	50.00%
04/27/2010	---	$-0.08	-60.00%
02/09/2010	---	$-0.07	12.50%
10/27/2009	---	$-0.06	14.29%
07/30/2009	---	$0.08	---
05/12/2009	---	$-0.08	---
02/11/2009	---	$-0.13	---
11/13/2008	---	$-0.12	---
07/31/2008	---	$-0.10	---
05/14/2008	---	$-0.09	---
02/19/2008	---	$-0.11	---
10/23/2007	---	$-0.10	---
08/02/2007	---	$-0.11	---
05/01/2007	---	$-0.11	---
02/06/2007	---	$-0.14	---
11/01/2006	---	$-0.09	---
07/26/2006	---	$-0.13	---
04/27/2006	---	$-0.11	---
02/09/2006	---	$-0.12	---
11/02/2005	---	$-0.13	---
07/27/2005	---	$-0.12	---
04/20/2005	---	$-0.13	---
02/08/2005	---	$-0.14	---
11/02/2004	---	$-0.13	---
07/20/2004	---	$-0.12	---
04/21/2004	---	$-0.11	---
02/04/2004	---	$-0.13	---
10/29/2003	---	$-0.12	---
07/23/2003	---	$-0.09	---
03/31/2003	---	$-0.09	---
12/31/2002	---	$-0.12	---
09/30/2002	---	$-0.12	---
06/30/2002	---	$-0.11	---
04/24/2002	---	$-0.12	29.41%
02/13/2002	---	$-0.16	15.79%
10/25/2001	---	$-0.14	12.50%
07/25/2001	---	$-0.15	0.00%
04/30/2001	---	$-0.14	-7.69%
02/14/2001	---	$-0.06	25.00%
10/31/2000	---	$-0.24	-50.00%

More About Compugen

Website

https://cgen.com

Country

USA

Full Time Employees

Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe. The company's pipeline consists of COM701, an immuno-oncology pipeline program with an anti-PVRIG antibody; COM902, a therapeutic anti-TIGIT antibody, are in Phase 1 clinical trials and have been evaluated for the treatment of solid tumors as a monotherapy and in combination of PVRIG/PD-1 and PVRIG/TIGIT, as well as PVRIG/PD-1/TIGIT blockade; Bapotulimab, a therapeutic antibody targeting ILDR2 that is evaluated in Phase I clinical trials in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase III clinical study in patients with advanced or metastatic non-small cell lung cancer. Its preclinical therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and Gilead Sciences, Inc. for the research, development, manufacturing, and commercialization of COM503 and other products. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.

“Compugen Earnings” Can Refer to the Compugen Earnings Date

Some people say “Compugen earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Compugen position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Compugen Stock on the Earnings Date

If you own Compugen stock (CGEN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Compugen might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Compugen shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Compugen Earnings

You can contact us any time if you would like to ask questions about Compugen earnings or anything else related to the stock market.